Adma Biologics (ADMA) EBT Margin (2011 - 2025)
Adma Biologics (ADMA) posted EBT Margin of 86.99% for Q4 2025, down 345.74% on a QoQ basis from 35.4% in Q3 2025, and down 11652.0% year-over-year from N/an in Q4 2024.
Adma Biologics (ADMA) EBT Margin (2011 - 2025) Analysis & Trends
Adma Biologics' EBT Margin history runs 13 years deep, the most recent figure standing at 86.99% for Q4 2025.
- Quarterly EBT Margin fell 11652.0% year-over-year to 86.99% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (down 2948.0% YoY) and the FY2024 annual result came in at 29.48%, changed N/A from the prior year.
- EBT Margin was 86.99% for Q4 2025 at Adma Biologics, down from 35.4% in the prior quarter.
- Across five years, EBT Margin topped out at 35.4% in Q3 2025 and bottomed at 114.26% in Q1 2021.
- A 5-year average of 19.24% and a median of 11.26% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2021 — EBT Margin jumped 15346 bps — and 2025, when it sank 11652 bps.
- Adma Biologics' EBT Margin stood at 45.72% in 2021, then climbed by 18 bps to 37.29% in 2022, then soared by 138 bps to 14.33% in 2023, then soared by 106 bps to 29.53% in 2024, then plunged by 395 bps to 86.99% in 2025.
- Business Quant data shows ADMA's EBT Margin at 86.99% in Q4 2025, 35.4% in Q3 2025, and 32.87% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -86.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -86.99% |
| Sep 30, 2025 | 35.40% |
| Jun 30, 2025 | 32.87% |
| Mar 31, 2025 | 29.14% |
| Dec 31, 2024 | 29.53% |
| Sep 30, 2024 | 30.67% |
| Jun 30, 2024 | 33.45% |
| Mar 31, 2024 | 22.47% |
| Dec 31, 2023 | 14.33% |
| Sep 30, 2023 | 2.33% |
| Jun 30, 2023 | -10.60% |
| Mar 31, 2023 | -11.93% |
| Dec 31, 2022 | -37.29% |
| Sep 30, 2022 | -36.24% |
| Jun 30, 2022 | -18.33% |
| Mar 31, 2022 | -62.44% |
| Dec 31, 2021 | -45.72% |
| Sep 30, 2021 | -85.74% |
| Jun 30, 2021 | -105.56% |
| Mar 31, 2021 | -114.26% |